Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications

Front Pharmacol. 2023 Nov 22:14:1281382. doi: 10.3389/fphar.2023.1281382. eCollection 2023.
No abstract available

Keywords: antihypertensive agents; endothelial dysfunction; genetic polymorphisms; matrix metalloproteinase (MMP)-2; nicotinamide phosphoribosyltransferase (NAMPT); nitric oxide; preeclampsia; tissue inhibitor of metalloproteinase (TIMP)-3.